Ruxolitinib approved for steroid-refractory acute and chronic GVHD

被引：0
|
作者：
不详
机构：
来源：
TRANSFUSION MEDICINE AND HEMOTHERAPY | 2022年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [31] Ruxolitinib in chronic steroid-refractory graft-versus-host-disease.
    Kovalenko, Iuliia
    Saleem, Tabinda
    Laek, Babray
    Ali, Rimsha
    Mirza, Taaha Muddassir
    Chattaraj, Asmi
    Wahab, Ahsan
    Din, Asma Tamez Ud
    Qurashi, Hafiz
    Golubykh, Konstantin
    Malik, Maidah
    Khan, Rafiullah
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [33] Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Diseas
    Toama, Wael
    Fiala, Mark A.
    Pusic, Iskra
    Westervelt, Peter
    DiPersio, John F.
    Schroeder, Mark A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [34] Use of Ruxolitinib in Pediatric Patients with Steroid-Refractory Graft-versus-host Disease (GVHD)
    Becilli, Marco
    Merli, Pietro
    Pagliara, Daria
    Galaverna, Federica
    Algeri, Mattia
    Gaspari, Stefania
    Boccieri, Emilia
    Carta, Roberto
    Ruggeri, Annalisa
    Locatelli, Franco
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 631 - 631
  • [35] Treatment of steroid-refractory acute and chronic graft-versus-host disease with ruxolitinib in adults and children
    Moiseev, Ivan
    Morozova, Elena
    Barabanshikova, Maria
    Kozlov, Andrey
    Rudakova, Tatyana
    Klimova, Olesya
    Tcvetkov, Nikolai
    Pirogova, Olga
    Borzenkova, Evgeniya
    Kozhokar, Polina
    Ekushev, Kirill
    Paina, Olesya
    Bykova, Tatyana
    Darskaya, Elena
    Bondarenko, Sergey
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2018, 53 : 461 - 462
  • [36] Pulse cyclophosphamide in the treatment of steroid-refractory GVHD
    Mayer, J
    Oborilova, A
    Krejci, M
    Doubek, M
    Brychtova, Y
    BONE MARROW TRANSPLANTATION, 2003, 31 : S126 - S127
  • [37] Protection of the endothelium during steroid-refractory GVHD
    Cordes, Steffen
    Mokhtarias, Zeinab
    Bartosova, Maria
    Riesner, Katarina
    Mertlitz, Sarah
    Mengwasser, Joerg
    Shi, Yu
    Kalupa, Martina
    McGearey, Aleixandria
    Schrezenmeier, Jens
    Bullinger, Lars
    Diaz-Ricart, Maribel
    Palomo, Marta
    Carrreras, Enric
    Beutel, Gernot
    Schmitt, Claus Peter
    Beilhack, Andreas
    Penack, Olaf
    BONE MARROW TRANSPLANTATION, 2019, 54 : 89 - 90
  • [38] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
  • [39] Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
    Jagasia, Madan
    Perales, Miguel-Angel
    Schroeder, Mark A.
    Ali, Haris
    Shah, Nirav N.
    Chen, Yi-Bin
    Fazal, Salman
    Dawkins, Fitzroy W.
    Arbushites, Michael C.
    Tian, Chuan
    Connelly-Smith, Laura
    Howell, Michael D.
    Khoury, H. Jean
    BLOOD, 2020, 135 (20) : 1739 - 1749
  • [40] Rituximab therapy for steroid-refractory chronic GVHD: Safety and efficacy analysis.
    Cutler, C
    Miklos, D
    Lee, SJ
    Woo, SB
    Treister, N
    Bienfang, D
    Klickstein, L
    Levin, J
    Miller, KH
    Reynolds, C
    Pasek, M
    Ho, V
    Ritz, J
    Antin, JH
    Soiffer, R
    Alyea, E
    BLOOD, 2004, 104 (11) : 619A - 620A
12345